A Case of Nummular Eczema-Like Eruption after Secukinumab Treatment
- Author:
Dae Hwi EUN
1
;
Dongmin KIM
;
Jisu LEE
;
Tae Young YOON
;
Ji Yeoun LEE
Author Information
1. Department of Dermatology, Chungbuk National University College of Medicine, Cheongju, Korea
- Publication Type:Case Report
- From:Korean Journal of Dermatology
2022;60(2):135-138
- CountryRepublic of Korea
- Language:English
-
Abstract:
Secukinumab is an anti-interleukin 17A monoclonal antibody used for treating chronic plaque psoriasis. Eczematous eruption is a relatively unknown adverse effect of secukinumab. A 32-year-old man developed eczematous eruptions on both lower extremities following secukinumab treatment for severe plaque psoriasis. The lesions were clinically diagnosed as a nummular eczema-like eruption and were treated with topical corticosteroids without switching or stopping secukinumab. Considering the increased use of secukinumab and other interleukin-17A inhibitors, dermatologists should be aware of the cutaneous side effects of the drug.
